Cargando…

The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) is associated with moderate responsiveness to levodopa treatment and a possible lack of typical PSP milestones. The clinical manifestation of PSP-P poses difficulties in neurological examination. In the early stages it is often misdiagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Alster, Piotr, Madetko-Alster, Natalia, Migda, Bartosz, Nieciecki, Michał, Koziorowski, Dariusz, Królicki, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600948/
https://www.ncbi.nlm.nih.gov/pubmed/36292111
http://dx.doi.org/10.3390/diagnostics12102421
_version_ 1784816957283893248
author Alster, Piotr
Madetko-Alster, Natalia
Migda, Bartosz
Nieciecki, Michał
Koziorowski, Dariusz
Królicki, Leszek
author_facet Alster, Piotr
Madetko-Alster, Natalia
Migda, Bartosz
Nieciecki, Michał
Koziorowski, Dariusz
Królicki, Leszek
author_sort Alster, Piotr
collection PubMed
description Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) is associated with moderate responsiveness to levodopa treatment and a possible lack of typical PSP milestones. The clinical manifestation of PSP-P poses difficulties in neurological examination. In the early stages it is often misdiagnosed as Parkinson’s Disease, and in the more advanced stages PSP-P shows more symptoms in common with Multiple System Atrophy—Parkinsonian type (MSA-P). The small number of tools enabling differential diagnosis of PSP-P and MSA leads to the necessity of searching for parameters facilitating in vivo diagnosis. In this study, 14 patients with PSP-P and 21 patients with MSA-P were evaluated using Single Photon Emission Computed Tomography. Considering the fact that PSP is linked with frontal deficits, regions of the frontal lobe were assessed in the context of hypoperfusion and their possible usefulness in the differential diagnosis with MSA-P. The outcome of the work revealed that the right middle frontal gyrus was the region most significantly affected in PSP-P.
format Online
Article
Text
id pubmed-9600948
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96009482022-10-27 The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Alster, Piotr Madetko-Alster, Natalia Migda, Bartosz Nieciecki, Michał Koziorowski, Dariusz Królicki, Leszek Diagnostics (Basel) Brief Report Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) is associated with moderate responsiveness to levodopa treatment and a possible lack of typical PSP milestones. The clinical manifestation of PSP-P poses difficulties in neurological examination. In the early stages it is often misdiagnosed as Parkinson’s Disease, and in the more advanced stages PSP-P shows more symptoms in common with Multiple System Atrophy—Parkinsonian type (MSA-P). The small number of tools enabling differential diagnosis of PSP-P and MSA leads to the necessity of searching for parameters facilitating in vivo diagnosis. In this study, 14 patients with PSP-P and 21 patients with MSA-P were evaluated using Single Photon Emission Computed Tomography. Considering the fact that PSP is linked with frontal deficits, regions of the frontal lobe were assessed in the context of hypoperfusion and their possible usefulness in the differential diagnosis with MSA-P. The outcome of the work revealed that the right middle frontal gyrus was the region most significantly affected in PSP-P. MDPI 2022-10-07 /pmc/articles/PMC9600948/ /pubmed/36292111 http://dx.doi.org/10.3390/diagnostics12102421 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Alster, Piotr
Madetko-Alster, Natalia
Migda, Bartosz
Nieciecki, Michał
Koziorowski, Dariusz
Królicki, Leszek
The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
title The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
title_full The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
title_fullStr The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
title_full_unstemmed The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
title_short The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
title_sort assessment of subregions in the frontal lobe may be feasible in the differential diagnosis of progressive supranuclear palsy—parkinsonism predominant (psp-p) and multiple system atrophy (msa)
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600948/
https://www.ncbi.nlm.nih.gov/pubmed/36292111
http://dx.doi.org/10.3390/diagnostics12102421
work_keys_str_mv AT alsterpiotr theassessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT madetkoalsternatalia theassessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT migdabartosz theassessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT niecieckimichał theassessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT koziorowskidariusz theassessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT krolickileszek theassessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT alsterpiotr assessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT madetkoalsternatalia assessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT migdabartosz assessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT niecieckimichał assessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT koziorowskidariusz assessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa
AT krolickileszek assessmentofsubregionsinthefrontallobemaybefeasibleinthedifferentialdiagnosisofprogressivesupranuclearpalsyparkinsonismpredominantpsppandmultiplesystematrophymsa